My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1901

    1.

    Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.

    Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.

    Diabetes. 2003 Feb;52(2):453-62.PMID: 12540621 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study.

    Goff DC Jr, D'Agostino RB Jr, Haffner SM, Otvos JD.

    Metabolism. 2005 Feb;54(2):264-70.PMID: 15690322 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study.

    Soedamah-Muthu SS, Chang YF, Otvos J, Evans RW, Orchard TJ; Pittsburgh Epidemiology of Diabetes Complications Study.

    Diabetologia. 2003 May;46(5):674-82. Epub 2003 May 13.PMID: 12743701 [PubMed - indexed for MEDLINE]Related articles

    4.

    Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women.

    MacLean PS, Vadlamudi S, MacDonald KG, Pories WJ, Houmard JA, Barakat HA.

    Metabolism. 2000 Mar;49(3):285-92.PMID: 10726902 [PubMed - indexed for MEDLINE]Related articles

    5.

    Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.

    Festa A, Williams K, Hanley AJ, Otvos JD, Goff DC, Wagenknecht LE, Haffner SM.

    Circulation. 2005 Jun 28;111(25):3465-72.PMID: 15983261 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.

    Mostad IL, Bjerve KS, Lydersen S, Grill V.

    Eur J Clin Nutr. 2008 Mar;62(3):419-29. Epub 2007 Feb 28.PMID: 17327864 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women.

    Magkos F, Mohammed BS, Mittendorfer B.

    Int J Obes (Lond). 2008 Nov;32(11):1655-64. Epub 2008 Sep 9.PMID: 18779822 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Lipoprotein subclasses and particle sizes and their relationship with coronary artery calcification in men and women with and without type 1 diabetes.

    Colhoun HM, Otvos JD, Rubens MB, Taskinen MR, Underwood SR, Fuller JH.

    Diabetes. 2002 Jun;51(6):1949-56.PMID: 12031985 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia.

    Deeg MA, Buse JB, Goldberg RB, Kendall DM, Zagar AJ, Jacober SJ, Khan MA, Perez AT, Tan MH; GLAI Study Investigators.

    Diabetes Care. 2007 Oct;30(10):2458-64. Epub 2007 Jun 26.PMID: 17595355 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.

    Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.

    Clin Exp Hypertens. 2001 Aug;23(6):489-500. Erratum in: Clin Exp Hypertens 2001 Nov;23(8):667. PMID: 11478431 [PubMed - indexed for MEDLINE]Related articles

    11.

    Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses.

    Klein RL, McHenry MB, Lok KH, Hunter SJ, Le NA, Jenkins AJ, Zheng D, Semler AJ, Brown WV, Lyons TJ, Garvey WT; DCCT/EDIC Research Group.

    Metabolism. 2004 Oct;53(10):1296-304.PMID: 15375785 [PubMed - indexed for MEDLINE]Related articles

    12.

    Insulin sensitivity in type 2 diabetes is closely associated with LDL particle size.

    Krayenbuehl PA, Wiesli P, Schmid C, Lehmann R, Spinas GA, Berneis K.

    Swiss Med Wkly. 2008 May 3;138(19-20):275-80.PMID: 18491240 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.

    Ambrosch A, Mühlen I, Kopf D, Augustin W, Dierkes J, König W, Luley C, Lehnert H.

    Diabetes Care. 1998 Dec;21(12):2077-84.PMID: 9839097 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Low density lipoprotein particle size and risk factors of insulin resistance syndrome.

    Friedlander Y, Kidron M, Caslake M, Lamb T, McConnell M, Bar-On H.

    Atherosclerosis. 2000 Jan;148(1):141-9.PMID: 10580180 [PubMed - indexed for MEDLINE]Related articles

    15.

    Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.

    Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T.

    Diabetes. 2008 Aug;57(8):2022-7. Epub 2008 May 9.PMID: 18469202 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.

    Bavirti S, Ghanaat F, Tayek JA.

    Endocr Pract. 2003 Nov-Dec;9(6):487-93.PMID: 14715475 [PubMed - indexed for MEDLINE]Related articles

    17.

    The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease.

    Soedamah-Muthu SS, Colhoun HM, Thomason MJ, Betteridge DJ, Durrington PN, Hitman GA, Fuller JH, Julier K, Mackness MI, Neil HA; CARDS Investigators.

    Atherosclerosis. 2003 Apr;167(2):243-55.PMID: 12818407 [PubMed - indexed for MEDLINE]Related articles

    18.

    Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.

    Freedman DS, Otvos JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA.

    Arterioscler Thromb Vasc Biol. 1998 Jul;18(7):1046-53.PMID: 9672064 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.

    Freedman DS, Otvos JD, Jeyarajah EJ, Shalaurova I, Cupples LA, Parise H, D'Agostino RB, Wilson PW, Schaefer EJ.

    Clin Chem. 2004 Jul;50(7):1189-200. Epub 2004 Apr 23.PMID: 15107310 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.

    Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL; DCCT/EDIC Research Group.

    Kidney Int. 2003 Sep;64(3):817-28.PMID: 12911531 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity